Healthcare -
Biotechnology - NASDAQ - GB
$ 1.1
0 %
$ 37.3 M
Market Cap
-2.89
P/E
OKYO - COST OF REVENUE
Cost of Revenue OKYO - OKYO Pharma Limited
7.51 K
LAST VALUE
76.01%
2 YEAR CAGR
102.74%
5 YEAR CAGR
0.00%
10 YEAR CAGR